Mangaluru: Notorious ‘Target Gang’ leader, associate arrested in murder case

Mangaluru, June 17: As many as 47 buses have been arranged by the district administration to transport 1,043 II PU students from the border areas of Kerala to the respective examination centres in Dakshina Kannada.

The II PU English examination, which was postponed in Karnataka due to covid lockdown, will be held on June 18. A total of 26,942 students are expected to appear for the examination across the district. Among them 6322 students have chosen to write their exam in the centres near to their hometown, following the COVID-19 pandemic. As many as 1,043 students are expected to come from Kerala.

22 KSRTC buses and 11 schools buses have been arranged from Talapady toll gate near Mariyashrama Church, 2 each KSRTC buses from Punyakoti Nagara in Mudipu, Bayar and Anekal in Vittal border, 1 KSRTC bus from Pathur in Kurnadu border, 3 KSRTC buses from Saradka in Vittal border, school buses from Kayar Padav in Puttur border, Panjikallu in Sullia border, Karike in Sullia border and Alatti Baddadka have been arranged.

The students have been asked to be present at a designated place to board the bus at 7 am and have to get their hall ticket and identity card, said DC Sindhu B Rupesh.

All the students should mandatorily wear masks and use sanitisers before entering the examination centres. The principals of colleges, where students from Kerala, are studying have been asked to deploy staff to make arrangements to ensure that students reach the examination centres on time and get back home after the exam.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Bantwal, Jan 15: Two people died in a head-on collision between two two-wheelers at Mani-Mysuru Highway in Bantwal last night, police said on Wednesday.

Police said that Parikshit (19) and Padmanabha Gowda (28) were heading towards Mane while Mohammed Ajmal (19) on his activa was on his way towards Kodaje when they collided head-on.

All the victims were immediately rushed to hospital for treatment where two of them breathed its last after not responding to the treatment.

Parikshit and Ajmal lost their lives while Gowda suffered critical injuries, the police said.

In another road accident reported from Kodangayi near Radukatte in Vittla, seven people including women and children sustained injuries when a Maruti Omni and another vehicle collided here on Tuesday evening.